MYLAN IRELAND C/O ALLOGA RDC, — Rivaroxaban Importer Profile
Pharmaceutical Importer · #1 buyer for Rivaroxaban · $2.4M import value · 144 shipments · NETHERLANDS · DGFT Verified
MYLAN IRELAND C/O ALLOGA RDC, is the #1 importer of Rivaroxaban from India with $2.4M in import value and 144 verified shipments. MYLAN IRELAND C/O ALLOGA RDC, holds a 7.9% market share in Rivaroxaban imports based in NETHERLANDS. The company sources from 1 verified supplier across 116 formulations shipped to 1 country. Overall, MYLAN IRELAND C/O ALLOGA RDC, imports 5 pharmaceutical products worth $11.0M across 4 therapeutic categories.
MYLAN IRELAND C/O ALLOGA RDC, — Rivaroxaban Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Rivaroxaban to MYLAN IRELAND C/O ALLOGA RDC,?
Verified from 144 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MYLAN LABORATORIES LIMITED | $2.4M | 144 | 100.0% |
MYLAN IRELAND C/O ALLOGA RDC, sources Rivaroxaban from 1 verified Indian supplier based on 144 customs records. The primary supplier is MYLAN LABORATORIES LIMITED accounting for 100.0% of imports.
How Does MYLAN IRELAND C/O ALLOGA RDC, Compare to Nearest Rivaroxaban Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MYLAN IRELAND C/O ALLOGA RDC, ★ | NETHERLANDS | $4.2M | 83 | $50.0K |
| 2 | PHARMADOX HEALTHCARE LTD | MALTA | $3.9M | 194 | $20.3K |
| 4 | APOTEX INC | CANADA | $1.3M | 27 | $46.9K |
MYLAN IRELAND C/O ALLOGA RDC, ranks #1 among 497 Rivaroxaban importers from India. Average shipment value of $50.0K compared to the market average of $33.2K. The closest competitors by value are PHARMADOX HEALTHCARE LTD and APOTEX INC.
Where Does MYLAN IRELAND C/O ALLOGA RDC, Import Rivaroxaban To?
Destination countries from 144 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| NETHERLANDS | $2.4M | 144 | 100.0% |
MYLAN IRELAND C/O ALLOGA RDC, imports Rivaroxaban to 1 country. The primary destination is NETHERLANDS receiving 100.0% of shipments worth $2.4M.
What Rivaroxaban Formulations Does MYLAN IRELAND C/O ALLOGA RDC, Import?
| Formulation | Value | Shipments |
|---|---|---|
| RIVAROXABAN TAB 20MG 100BT FI/SE VIA PACKS 26233NOS | $83.5K | 3 |
| RIVAROXABAN TAB 10MG 30BL FR VIA (PACKS 3 X 10S BLISTER)(73105 PACKS X 3X10S=2193150 NOS)NOS | $55.6K | 3 |
| HARMLESS MEDICINES, RIVAROXABAN TAB 10MG30BL IE VIA (2760 PACKS) | $50.0K | 1 |
| HARMLESS MEDICINES, RIVAROXABAN TAB 15MG30BL FI VIA (2313 PACKS) | $50.0K | 1 |
| HARMLESS MEDICINES, RIVAROXABAN TAB 10MG30BL FI VIA (2281 PACKS) | $50.0K | 1 |
| HARMLESS MEDICINES, RIVAROXABAN TAB 10MG30BL SP DE VIA (2257 PACKS) | $50.0K | 1 |
| HARMLESS MEDICINES, RIVAROXABAN TAB 10MG30BL FR VIA (18961 PACKS) | $50.0K | 1 |
| HARMLESS MEDICINES, RIVAROXABAN TAB 10MG100BL DK/IS/NO VIA (5081 PACKS) | $50.0K | 1 |
| HARMLESS MEDICINES, RIVAROXABAN TAB 10MG30BL PT VIA (14449 PACKS) | $50.0K | 1 |
| HARMLESS MEDICINES, RIVAROXABAN TAB 10MG30BL IT MY (14065 PACKS) | $50.0K | 1 |
MYLAN IRELAND C/O ALLOGA RDC, imports 116 distinct Rivaroxaban formulations from India. The top formulation is RIVAROXABAN TAB 20MG 100BT FI/SE VIA PACKS 26233NOS with 3 shipments worth $83.5K.
Who Are the Top Buyers of Rivaroxaban from India and How Much Does MYLAN IRELAND C/O ALLOGA RDC, Import?
India exported $16.5M worth of Rivaroxaban through 5,361 shipments from 221 suppliers to 115 countries, serving 497 buyers globally. MYLAN IRELAND C/O ALLOGA RDC, imports $2.4M of this total, accounting for 7.9% of India's Rivaroxaban exports with 144 shipments from NETHERLANDS. This is verified from 144 customs shipment records covering 116 distinct formulations.
What Is the Average Order Value for MYLAN IRELAND C/O ALLOGA RDC,'s Rivaroxaban Imports?
MYLAN IRELAND C/O ALLOGA RDC,'s average Rivaroxaban order value is $16.8K per consignment, based on 144 shipments totaling $2.4M. MYLAN IRELAND C/O ALLOGA RDC, is based in NETHERLANDS and ranks #1 among all Rivaroxaban importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Rivaroxaban to MYLAN IRELAND C/O ALLOGA RDC,?
MYLAN IRELAND C/O ALLOGA RDC, sources Rivaroxaban from 1 verified Indian supplier: MYLAN LABORATORIES LIMITED ($2.4M, 100.0%). This is based on 144 customs records.
How Does MYLAN IRELAND C/O ALLOGA RDC, Compare to Other Rivaroxaban Importers?
MYLAN IRELAND C/O ALLOGA RDC, ranks #1 among 497 Rivaroxaban importers from India with a 7.9% market share. The top 3 importers are MYLAN IRELAND C/O ALLOGA RDC, ($4.2M), PHARMADOX HEALTHCARE LTD ($3.9M), APOTEX INC ($1.3M). MYLAN IRELAND C/O ALLOGA RDC, processed 144 shipments from NETHERLANDS.
What Other Cardiovascular Products Does MYLAN IRELAND C/O ALLOGA RDC, Import?
MYLAN IRELAND C/O ALLOGA RDC, also imports these cardiovascular products. Each links to the detailed product page.
About MYLAN IRELAND C/O ALLOGA RDC,
MYLAN IRELAND C/O ALLOGA RDC, imports 5 products worth $11.0M. Beyond Rivaroxaban, top products include Lansoprazole, Sitagliptin, Darunavir, Lisinopril. View the complete MYLAN IRELAND C/O ALLOGA RDC, profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rivaroxaban — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rivaroxaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MYLAN IRELAND C/O ALLOGA RDC, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MYLAN IRELAND C/O ALLOGA RDC,'s capped import value divided by total capped export value for Rivaroxaban across all Indian exporters.
- 5.Verified Records: This page is backed by 144 individual customs records matching MYLAN IRELAND C/O ALLOGA RDC, importing Rivaroxaban, covering 116 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 115+ countries, 497+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rivaroxaban Import Data for MYLAN IRELAND C/O ALLOGA RDC,
Access order-level details, pricing data, supplier connections, and competitive analysis for MYLAN IRELAND C/O ALLOGA RDC,'s Rivaroxaban imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MYLAN IRELAND C/O ALLOGA RDC,
Full Company Profile →
5 products · $11.0M total trade · 4 categories
MYLAN IRELAND C/O ALLOGA RDC, × Rivaroxaban
Verified from customs records
Company Overview
Top Products by MYLAN IRELAND C/O ALLOGA RDC,
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MYLAN IRELAND C/O ALLOGA RDC,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rivaroxaban. For current order-level data, contact TransData Nexus.